Fasting Serum IGFBP-1 as a Marker of Insulin Resistance in Diverse School Age Groups.

Front Endocrinol (Lausanne) · 2022 · PMC9108162 · PMID 35586622

Europe PMC DOI

hedged sentence

0.1400

closest p · 2.8× alpha

0.1400

boldest claim

The sentences

did not achieve significancep = 0.14not close (p > 0.1)

IGFBP-1 was lower at 9.3 ± 9.4 ng/ml, while in the group with a BMI Z-score 1 to 2 SDS, IGFBP1 was 13.9 ± 8.9, but it did not achieve significance with p = 0.14.

also in 1,397 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.